Ondas Raises 2026 Revenue View: Can It Deliver the Required H2 Ramp?

Ondas raised its 2026 revenue outlook to $525-$550 million and guided for Q3 revenue of $140-$155 million, implying roughly 76% sequential growth at the midpoint. Q2 revenue rose more than 13-fold year over year to $83.8 million, supported by a $613 million reported backlog, or $757 million pro forma including DZYNE and Cyberhawk. However, the forecast requires a steep second-half production and order-conversion ramp amid supply-chain, acquisition-integration and competitive risks; ONDS shares have fallen 25.8% over the past month and consensus earnings estimates have been revised lower.

Analysis

ONDS' apparent sales multiple discount is unlikely to close merely on guidance: the market is assigning a haircut to acquired revenue, working-capital intensity, and the probability that contracted demand converts into accepted deliveries on schedule. The critical valuation variable over the next two quarters is not bookings but gross-margin and cash-conversion performance; a production ramp that requires inventory builds, expedited components, or field remediation could produce substantial revenue while worsening free-cash-flow losses and necessitating incremental equity financing.

AVAV is the cleaner beneficiary of the same defense-autonomy spending cycle because its broader installed base, program diversification, and manufacturing maturity reduce single-program conversion risk. RCAT has greater operating leverage to small-drone demand but remains exposed to a narrower customer/program set; if procurement shifts toward proven platforms, AVAV can take share even while aggregate drone budgets expand. Suppliers of secure radios, optics, batteries, and propulsion could become the near-term bottleneck, making delivery timing more important than nominal defense award values.

For ONDS, the immediate catalyst path is evidence of quarterly delivery acceptance and stable gross margin in the next two reports; the 6-18 month upside case requires successful integration without dilution. Consensus may be too focused on the headline revenue ramp and too little on receivables, inventory, customer-concentration disclosures, and any change in payment milestones. The bearish thesis is falsified if ONDS meets the next-quarter revenue range while expanding gross margin, keeping operating cash burn contained, and reiterating full-year targets without a material increase in share count.

Key Decisions for Investors

• Maintain an underweight/avoid stance on ONDS until the next earnings release validates delivery conversion: require revenue within or above the guided range, sequential gross-margin stability or improvement, and no material deterioration in operating cash burn. Treat a guidance cut, inventory/receivables spike, or equity raise as a downside trigger rather than averaging down.
• Implement a 1-3 month relative-value trade: long AVAV / short ONDS in beta-adjusted dollar amounts. The thesis is execution-quality dispersion within defense autonomy; target a 10-15% relative move, with a stop if ONDS demonstrates on-time deliveries plus margin expansion while AVAV lowers fiscal-year guidance.
• Use RCAT only as a high-volatility tactical long after confirmation that production capacity is translating into deliveries, not as a substitute for AVAV. Size at no more than one-half the AVAV exposure; upside is meaningful if program awards convert rapidly, but a missed quarterly delivery cadence can compress its premium growth multiple quickly.
• Set a diligence alert for ONDS' cash-flow statement and acquisition accounting: rising deferred revenue would support backlog quality, whereas rising unbilled receivables, inventory, integration charges, or revised payment terms would indicate that reported revenue is being purchased with working capital. Do not use options until liquidity, implied volatility, and borrow availability are verified.